Funding for this research was provided by:
University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (N/A)
Received: 22 January 2020
Accepted: 1 September 2020
First Online: 21 September 2020
Ethics approval and consent to participate
: Informed consent was obtained from all study respondents. The study was approved by the UTMDACC Institutional Review Board (PA17–0473) and the University of Texas Health Science Center at Houston Institutional Review Board (HSC-MS-17-0831).
: Not applicable.
: The authors declare that they have no competing interests.